(NASDAQ: BHST) Bioharvest Sciences's forecast annual revenue growth rate of 53.11% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Bioharvest Sciences's revenue in 2025 is $27,704,000.On average, 2 Wall Street analysts forecast BHST's revenue for 2025 to be $700,039,726, with the lowest BHST revenue forecast at $695,361,243, and the highest BHST revenue forecast at $704,718,210. On average, 2 Wall Street analysts forecast BHST's revenue for 2026 to be $1,196,998,621, with the lowest BHST revenue forecast at $1,017,830,038, and the highest BHST revenue forecast at $1,376,167,205.
In 2027, BHST is forecast to generate $1,728,872,864 in revenue, with the lowest revenue forecast at $1,471,816,197 and the highest revenue forecast at $1,985,929,531.